The global naltrexone market is slated to grow on an exponential note due to increase in the incidence of autoimmune diseases and more number of people getting addicted to alcohol and opioids.
Naltrexone helps in decreasing the inflammatory response of the immune system to the healthy tissues. Moreover, it aids in decreasing the cravings related to alcoholism and intake of toxic drugs.
The companies operating in the naltrexone market are working toward deploying quicker approaches in order to start with clinical trials of extended-release naltrexone, so as to treat opioid disorder with immediate effect.
They are also exploring the amalgamation of bupropion and naltrexone for reducing the frequency of smoking and losing weight. Some of the players restrict the use of naltrexone only for internal research and passing on the findings to those who make the product for patients.
Naltrexone is sold under brand name ‘Revia’. It is a medication basically used for curing alcoholism or opioid use disorder by cutting down on cravings linked with substance use disorder. It has also been found quite effective with respect to treatment of the other addictions and recommended for off-label treatment.
Growing awareness regarding availability of naltrexone as a choice for treatment of addiction along with encouragement from the governments regarding rehabilitation and treatment are the factors contributing towards naltrexone market growth.
Developments in drug formulations as well as administration techniques have raised the therapeutic uses of naltrexone.
The naltrexone market landscape is getting shaped based on synchronization amongst production costs, competitor strategies, and regional demand variations.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
As per the National Health Council, autoimmune conditions are reaching the epidemic levels, with certain studies anticipating rise of 3-12% every year.
It further states that amongst the test subjects, incidence of antinuclear antibodies (ANA) (a common biomarker for autoimmunity) increased almost fourfold in the last few years.
The National Health Council also states that autoimmune diseases end up affecting over 50 million Americans on an average.
Naltrexone is reported to work by modulation of immune system and may also aid in reduction of inflammation and promotion of self-tolerance. In other words, naltrexone helps in increasing the release of endorphins, which, in turn, help in moderating immune system.
Need to combat autoimmune conditions is thus catalyzing the naltrexone market.
Opioids are known for having analgesic as well as sedative effects. They are known for causing euphoria. They include morphine, heroin, codeine, methadone, fentanyl, tramadol, and various other similar substances.
Opioid dependence is referred to as a disorder that causes the patient to lose control over himself/herself. As per the WHO, close to 296 people worldwide had used drugs atleast once in the year 2021. It further states that out of them 60 million consumed opioids.
Overdose of opioids is likely to result into unconsciousness, pinpoint pupils, difficulties with breathing, and pinpoint pupils.
Naltrexone’s opioid antagonist properties help in reducing reinforcing effects of opioids and also curb the cravings for alcohol and opioid, thereby expanding the naltrexone market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest naltrexone market analysis, North America dominated the naltrexone uses landscape in 2023 and the scenario is expected to remain unchanged during the forecast period.
This is attributed to continuous advancements in healthcare infrastructure in the U.S. and Canada followed by spur in R&D activities throughout the year.
Asia Pacific’s significant naltrexone market share is ascribed to the rise in awareness quotient regarding the importance of getting rid of the addictions to alcohol and opioids. The government and non-government bodies are propagating the usage of antagonists like naltrexone at the larger level.
The key participants are engaging in new product launches, for which they are expanding their production capabilities by shifting their base or acquisitions.
For instance, in April 2021, Olympus Corporation shifted its Therapeutic Solutions Division’s global headquarters to the U.S. from Tokyo for better access to medical sector.
Taj Pharmaceuticals, IVAX Paper Chemicals, Faran Shimi, AdooQ Bioscience LLC, Sun Pharmaceutical Industries Ltd., Sanofi S.A., Freedom Pharmaceuticals, Ascent Scientific, Teva Pharmaceutical Industries Ltd., and Mallinckrodt Pharmaceuticals are some of the key players covered in the naltrexone market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 21.0 Bn |
| Market Forecast (Value) in 2034 | US$ 30.8 Bn |
| Growth Rate (CAGR) | 3.6% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 21.0 Bn in 2023
It is projected to grow at a CAGR of 3.6% from 2024 to 2034
Growing autoimmune conditions and addiction to alcohol and opiate drugs
Hospitals & clinics segment accounted for the largest share in 2023
North America was the dominant region in 2023
Taj Pharmaceuticals, IVAX Paper Chemicals, Faran Shimi, AdooQ Bioscience LLC, Sun Pharmaceutical Industries Ltd., Sanofi S.A., Freedom Pharmaceuticals, Ascent Scientific, Teva Pharmaceutical Industries Ltd., and Mallinckrodt Pharmaceuticals
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Naltrexone Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Naltrexone Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Naltrexone Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
6.3.1. 25 mg
6.3.2. 50 mg
6.4. Market Attractiveness Analysis, by Type
7. Global Naltrexone Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Opioid Independence
7.3.2. Alcohol Independence
7.4. Market Attractiveness Analysis, by Application
8. Global Naltrexone Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Clinics
8.3.2. Rehabilitation Centers
8.3.3. Wellness Centers
8.3.4. Others (Research and Academic Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Naltrexone Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Naltrexone Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2020-2034
10.3.1. 25 mg
10.3.2. 50 mg
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Opioid Independence
10.4.2. Alcohol Independence
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Clinics
10.5.2. Rehabilitation Centers
10.5.3. Wellness Centers
10.5.4. Others (Research and Academic Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Naltrexone Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2020-2034
11.3.1. 25 mg
11.3.2. 50 mg
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Opioid Independence
11.4.2. Alcohol Independence
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Clinics
11.5.2. Rehabilitation Centers
11.5.3. Wellness Centers
11.5.4. Others (Research and Academic Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Naltrexone Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2020-2034
12.3.1. 25 mg
12.3.2. 50 mg
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Opioid Independence
12.4.2. Alcohol Independence
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Clinics
12.5.2. Rehabilitation Centers
12.5.3. Wellness Centers
12.5.4. Others (Research and Academic Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Naltrexone Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2020-2034
13.3.1. 25 mg
13.3.2. 50 mg
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Opioid Independence
13.4.2. Alcohol Independence
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Clinics
13.5.2. Rehabilitation Centers
13.5.3. Wellness Centers
13.5.4. Others (Research and Academic Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Naltrexone Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2020-2034
14.3.1. 25 mg
14.3.2. 50 mg
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Opioid Independence
14.4.2. Alcohol Independence
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Clinics
14.5.2. Rehabilitation Centers
14.5.3. Wellness Centers
14.5.4. Others (Research and Academic Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Taj Pharmaceuticals
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. IVAX Paper Chemicals
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Faran Shimi
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. AdooQ Bioscience LLC
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Sun Pharmaceutical Industries Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Sanofi S.A.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Freedom Pharmaceuticals
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Ascent Scientific
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Teva Pharmaceutical Industries Ltd.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Mallinckrodt Pharmaceuticals
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Naltrexone Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 02: Global Naltrexone Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 03: Global Naltrexone Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Naltrexone Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Naltrexone Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Naltrexone Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 07: North America Naltrexone Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 08: North America Naltrexone Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Naltrexone Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Naltrexone Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 11: Europe Naltrexone Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 12: Europe Naltrexone Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Naltrexone Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Naltrexone Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 15: Asia Pacific Naltrexone Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific Naltrexone Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Naltrexone Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Naltrexone Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 19: Latin America Naltrexone Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 20: Latin America Naltrexone Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Naltrexone Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Naltrexone Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 23: Middle East & Africa Naltrexone Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa Naltrexone Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Naltrexone Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Naltrexone Market Revenue (US$ Bn), by Type, 2023
Figure 03: Global Naltrexone Market Value Share, by Type, 2023
Figure 04: Global Naltrexone Market Revenue (US$ Bn), by Application, 2023
Figure 05: Global Naltrexone Market Value Share, by Application, 2023
Figure 06: Global Naltrexone Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Naltrexone Market Value Share, by End-user, 2023
Figure 08: Global Naltrexone Market Value Share, by Region, 2023
Figure 09: Global Naltrexone Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Naltrexone Market Value Share Analysis, by Type, 2023 and 2034
Figure 11: Global Naltrexone Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Naltrexone Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global Naltrexone Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: Global Naltrexone Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Naltrexone Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Naltrexone Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Naltrexone Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Naltrexone Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Naltrexone Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Naltrexone Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Naltrexone Market Value Share Analysis, by Type, 2023 and 2034
Figure 22: North America Naltrexone Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America Naltrexone Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Naltrexone Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Naltrexone Market Attractiveness Analysis, by Application, 2024-2034
Figure 26:North America Naltrexone Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Naltrexone Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Naltrexone Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Naltrexone Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Naltrexone Market Value Share Analysis, by Type, 2023 and 2034
Figure 31: Europe Naltrexone Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe Naltrexone Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Naltrexone Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Naltrexone Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe Naltrexone Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Naltrexone Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Naltrexone Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Naltrexone Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Naltrexone Market Value Share Analysis, by Type, 2023 and 2034
Figure 40: Asia Pacific Naltrexone Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific Naltrexone Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Naltrexone Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Naltrexone Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific Naltrexone Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Naltrexone Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Naltrexone Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Naltrexone Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Naltrexone Market Value Share Analysis, by Type, 2023 and 2034
Figure 49: Latin America Naltrexone Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America Naltrexone Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Naltrexone Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Naltrexone Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America Naltrexone Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Naltrexone Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Naltrexone Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Naltrexone Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Naltrexone Market Value Share Analysis, by Type, 2023 and 2034
Figure 58: Middle East & Africa Naltrexone Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa Naltrexone Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Naltrexone Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Naltrexone Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa Naltrexone Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Naltrexone Market
